CD274 and Miyoshi myopathy: Accordingly, the use of PDL1 inhibitor, which inhibited the BM-MSC-based suppression of CTLs and enhanced the CTL-dependent elimination of tumor cells, had beneficial effects in the treatment of MM patients [19].